Position in ARWR
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,974,924
-$139,929 QoQ
Shares Held
31,498
-1.1% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $466,757,935 across 164 Biotechnology names. ARWR ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
373,532 | $166,796,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
152,397 | $117,748,018 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,013 | $57,575,681 | |
| 4 | INSM |
INSMED Inc
|
283,141 | $46,299,216 | |
| 5 | INCY |
Incyte Corp
|
49,678 | $4,675,693 | |
| 6 | MRNA |
Moderna, Inc.
|
71,342 | $3,624,173 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
31,677 | $2,352,334 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
31,498 | $1,974,924 |
All Filings in ARWR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,974,924 | 31,498 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,114,853 | 31,855 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $964,271 | 27,958 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $508,380 | 32,176 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $432,229 | 33,927 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $852,204 | 45,330 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $684,245 | 35,325 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $755,815 | 29,081 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,017,931 | 35,592 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $895,080 | 29,251 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $697,088 | 25,943 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $944,847 | 26,496 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $662,127 | 26,068 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $1,222,681 | 30,145 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $916,179 | 27,721 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $962,535 | 27,337 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,869,861 | 40,658 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,241,672 | 48,894 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,804,542 | 44,923 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,377,948 | 52,861 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,297,662 | 49,731 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,540,552 | 46,143 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,536,897 | 35,692 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,582,438 | 36,639 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $653,366 | 22,710 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||